Short Interest in Sinopharm Group Co. Ltd. (OTCMKTS:SHTDY) Decreases By 32.6%

Sinopharm Group Co. Ltd. (OTCMKTS:SHTDY) was the target of a significant decline in short interest during the month of December. As of December 15th, there was short interest totaling 18,708 shares, a decline of 32.6% from the November 30th total of 27,751 shares. Based on an average daily trading volume, of 54,765 shares, the short-interest ratio is currently 0.3 days. Based on an average daily trading volume, of 54,765 shares, the short-interest ratio is currently 0.3 days.

Sinopharm Group Stock Performance

Shares of OTCMKTS SHTDY opened at $12.62 on Monday. Sinopharm Group has a 1 year low of $10.72 and a 1 year high of $14.13. The firm’s 50 day moving average price is $12.85 and its 200 day moving average price is $12.29.

Sinopharm Group Company Profile

Sinopharm Group Co, Ltd. (OTCMKTS:SHTDY) is one of China’s largest integrated healthcare companies and an indirect subsidiary of the state-owned China National Pharmaceutical Group Co, Ltd. The company operates through two primary segments—pharmaceutical distribution and retail pharmacy—offering comprehensive supply chain solutions that span procurement, storage, transportation and sales of medical products. With a broad portfolio that includes prescription drugs, over-the counter medicines, medical devices and consumables, Sinopharm serves hospitals, clinics, retail pharmacies and other healthcare institutions across mainland China.

In its distribution business, Sinopharm leverages an extensive logistics network, comprising hundreds of distribution centers and thousands of delivery vehicles, to ensure timely delivery of pharmaceuticals under stringent temperature-controlled conditions.